EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Therapeutic potential of hesperetin and isoliquiritigenin in chronic kidney disease

Meenu Chhikara, Mohd Aqil, Syed Ehtaisham Ul Haque, Mohd Akhtar, Abul Kalam Najmi

EXCLI Journal · 11.09.2026 · 25 · 1486-1487

DOI: 10.17179/excli2026-9683 ↗

Kurz gefasst

Leserbrief in der Zeitschrift EXCLI Journal, online erschienen am 11.09.2026. Verfasst von Meenu Chhikara und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.
  • Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.

Zitieren

APA

Chhikara, M., Aqil, M., Haque, S. E. U., Akhtar, M., & Najmi, A. K. (2026). Therapeutic potential of hesperetin and isoliquiritigenin in chronic kidney disease. EXCLI Journal, 25, 1486-1487. https://doi.org/10.17179/excli2026-9683

Vancouver

Chhikara M, Aqil M, Haque SEU, Akhtar M, Najmi AK. Therapeutic potential of hesperetin and isoliquiritigenin in chronic kidney disease. EXCLI Journal. 2026;25:1486-1487. doi:10.17179/excli2026-9683

BibTeX
@article{Chhikara2026,
  author = {Chhikara, Meenu and Aqil, Mohd and Haque, Syed Ehtaisham Ul and Akhtar, Mohd and Najmi, Abul Kalam},
  title = {Therapeutic potential of hesperetin and isoliquiritigenin in chronic kidney disease},
  journal = {EXCLI Journal},
  year = {2026},
  volume = {25},
  pages = {1486--1487},
  doi = {10.17179/excli2026-9683}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche